Patents

Oragenics Obtains U.S. Patent for IVIAT

October 17, 2011

Oragenics, Inc., Tampa, FL, has been issued patent No. 8,034,571 from the U.S. Patent and Trademark office for In Vivo Induced Antigen Technology (IVIAT). This platform technology is a novel approach for studying microbial pathogenesis that identifies genes of a pathogenic organism, which are differentially expressed during an actual human infection. IVIAT can be applied to all pathogenic bacteria, yeasts and parasites to rapidly identify proteins that are expressed when a pathogen infects a human. Such proteins are excellent targets for medical diagnostics and therapeutic strategies.
blog comments powered by Disqus
  • Choosing The Right Analytical Lab

    Choosing The Right Analytical Lab

    Maged Sharaf, PhD, American Herbal Products Association ||July 1, 2016
    Here are some important questions to consider when determining which contract laboratory will meet your needs.

  • Turning The Spotlight On Quality Assurance

    Turning The Spotlight On Quality Assurance

    Sean Moloughney, Editor ||July 1, 2016
    Proper utilization of scientifically valid analytical tools will continue to raise the quality bar.

  • Standards Development In Analytical Testing

    Standards Development In Analytical Testing

    Richard A. Lovett, JD, PhD, Contributing Writer ||July 1, 2016
    Official test methods for high profile products can help build better supply chain security.